RAPID MICRO BIOSYSTEMS INC-A (RPID) Fundamental Analysis & Valuation

NASDAQ:RPID • US75340L1044

Current stock price

2.43 USD
+0.03 (+1.25%)
At close:
2.43 USD
0 (0%)
Pre-Market:

This RPID fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

0

1. RPID Profitability Analysis

1.1 Basic Checks

  • RPID had negative earnings in the past year.
  • In the past year RPID has reported a negative cash flow from operations.
  • RPID had negative earnings in each of the past 5 years.
  • RPID had a negative operating cash flow in each of the past 5 years.
RPID Yearly Net Income VS EBIT VS OCF VS FCFRPID Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2019 2020 2021 2022 2023 2024 -20M -40M -60M

1.2 Ratios

  • Looking at the Return On Assets, with a value of -52.47%, RPID is doing worse than 85.71% of the companies in the same industry.
  • With a Return On Equity value of -99.91%, RPID is not doing good in the industry: 82.14% of the companies in the same industry are doing better.
Industry RankSector Rank
ROA -52.47%
ROE -99.91%
ROIC N/A
ROA(3y)-38.74%
ROA(5y)-42.64%
ROE(3y)-47.91%
ROE(5y)-72.28%
ROIC(3y)N/A
ROIC(5y)N/A
RPID Yearly ROA, ROE, ROICRPID Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2019 2020 2021 2022 2023 2024 0 1K 2K 3K

1.3 Margins

  • RPID has a Gross Margin of 7.72%. This is amonst the worse of the industry: RPID underperforms 91.07% of its industry peers.
  • The Profit Margin and Operating Margin are not available for RPID so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 7.72%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
RPID Yearly Profit, Operating, Gross MarginsRPID Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2019 2020 2021 2022 2023 2024 -100 -200 -300

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

4

2. RPID Health Analysis

2.1 Basic Checks

  • RPID does not have a ROIC to compare to the WACC, probably because it is not profitable.
  • There is no outstanding debt for RPID. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
RPID Yearly Shares OutstandingRPID Yearly Shares OutstandingYearly Shares Outstanding 2019 2020 2021 2022 2023 2024 10M 20M 30M 40M
RPID Yearly Total Debt VS Total AssetsRPID Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2019 2020 2021 2022 2023 2024 50M 100M 150M 200M

2.2 Solvency

  • RPID has an Altman-Z score of -7.46. This is a bad value and indicates that RPID is not financially healthy and even has some risk of bankruptcy.
  • Looking at the Altman-Z score, with a value of -7.46, RPID is doing worse than 87.50% of the companies in the same industry.
  • A Debt/Equity ratio of 0.43 indicates that RPID is not too dependend on debt financing.
  • RPID has a Debt to Equity ratio (0.43) which is comparable to the rest of the industry.
Industry RankSector Rank
Debt/Equity 0.43
Debt/FCF N/A
Altman-Z -7.46
ROIC/WACCN/A
WACC10.91%
RPID Yearly LT Debt VS Equity VS FCFRPID Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2019 2020 2021 2022 2023 2024 0 50M -50M 100M 150M 200M

2.3 Liquidity

  • RPID has a Current Ratio of 4.23. This indicates that RPID is financially healthy and has no problem in meeting its short term obligations.
  • The Current ratio of RPID (4.23) is better than 71.43% of its industry peers.
  • RPID has a Quick Ratio of 2.95. This indicates that RPID is financially healthy and has no problem in meeting its short term obligations.
  • The Quick ratio of RPID (2.95) is comparable to the rest of the industry.
Industry RankSector Rank
Current Ratio 4.23
Quick Ratio 2.95
RPID Yearly Current Assets VS Current LiabilitesRPID Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2019 2020 2021 2022 2023 2024 50M 100M 150M 200M

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

3

3. RPID Growth Analysis

3.1 Past

  • RPID shows a small growth in Earnings Per Share. In the last year, the EPS has grown by 0.93%.
EPS 1Y (TTM)0.93%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-27.27%
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%37.28%

3.2 Future

  • The Earnings Per Share is expected to grow by 11.13% on average over the next years. This is quite good.
  • The Revenue is expected to grow by 22.46% on average over the next years. This is a very strong growth
EPS Next Y17.78%
EPS Next 2Y15.24%
EPS Next 3Y13.11%
EPS Next 5Y11.13%
Revenue Next Year18.95%
Revenue Next 2Y18.69%
Revenue Next 3Y23.62%
Revenue Next 5Y22.46%

3.3 Evolution

RPID Yearly Revenue VS EstimatesRPID Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 20M 40M 60M 80M
RPID Yearly EPS VS EstimatesRPID Yearly EPS VS EstimatesYearly EPS VS Estimates 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 -0.5 -1 -1.5

More info and screens

Find the best growth stocksShow best growing peers

0

4. RPID Valuation Analysis

4.1 Price/Earnings Ratio

  • The Price/Earnings Ratio is negative for RPID. In the last year negative earnings were reported.
  • Besides the negative Price/Earnings Ratio, also the Forward Price/Earnings Ratio is negative for RPID. No positive earnings are expected for the next year.
Industry RankSector Rank
PE N/A
Fwd PE N/A
RPID Price Earnings VS Forward Price EarningsRPID Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 10 20 30

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
RPID Per share dataRPID EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 0.5 -0.5 -1

4.3 Compensation for Growth

  • A more expensive valuation may be justified as RPID's earnings are expected to grow with 13.11% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y15.24%
EPS Next 3Y13.11%

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

0

5. RPID Dividend Analysis

5.1 Amount

  • No dividends for RPID!.
Industry RankSector Rank
Dividend Yield 0%

More info and screens

Find the best dividend stocksShow peers with best dividend

RPID Fundamentals: All Metrics, Ratios and Statistics

RAPID MICRO BIOSYSTEMS INC-A

NASDAQ:RPID (3/25/2026, 8:00:02 PM)

Premarket: 2.43 0 (0%)

2.43

+0.03 (+1.25%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences
GICS IndustryLife Sciences Tools & Services
Earnings (Last)03-12
Earnings (Next)05-07
Inst Owners57.91%
Inst Owner Change0.29%
Ins Owners4.63%
Ins Owner Change9.59%
Market Cap110.47M
Revenue(TTM)N/A
Net Income(TTM)-44.29M
Analysts84
Price Target8.16 (235.8%)
Short Float %0.62%
Short Ratio0.79
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)0
Avg EPS beat(2)-4.27%
Min EPS beat(2)-4.49%
Max EPS beat(2)-4.04%
EPS beat(4)2
Avg EPS beat(4)0.82%
Min EPS beat(4)-4.49%
Max EPS beat(4)6.22%
EPS beat(8)4
Avg EPS beat(8)1.35%
EPS beat(12)7
Avg EPS beat(12)2.26%
EPS beat(16)8
Avg EPS beat(16)0.3%
Revenue beat(2)1
Avg Revenue beat(2)0.19%
Min Revenue beat(2)-0.85%
Max Revenue beat(2)1.23%
Revenue beat(4)3
Avg Revenue beat(4)2.67%
Min Revenue beat(4)-0.85%
Max Revenue beat(4)7.03%
Revenue beat(8)7
Avg Revenue beat(8)4.21%
Revenue beat(12)10
Avg Revenue beat(12)6.25%
Revenue beat(16)11
Avg Revenue beat(16)2.63%
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)0%
EPS NQ rev (3m)1.11%
EPS NY rev (1m)0%
EPS NY rev (3m)0%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)1.34%
Revenue NY rev (1m)0%
Revenue NY rev (3m)0.46%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 3.62
P/FCF N/A
P/OCF N/A
P/B 2.49
P/tB 2.49
EV/EBITDA N/A
EPS(TTM)-1.07
EYN/A
EPS(NY)-0.88
Fwd EYN/A
FCF(TTM)-0.85
FCFYN/A
OCF(TTM)-0.83
OCFYN/A
SpS0.67
BVpS0.98
TBVpS0.98
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
Industry RankSector Rank
ROA -52.47%
ROE -99.91%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 7.72%
FCFM N/A
ROA(3y)-38.74%
ROA(5y)-42.64%
ROE(3y)-47.91%
ROE(5y)-72.28%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score3
Asset Turnover0.36
Health
Industry RankSector Rank
Debt/Equity 0.43
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 25.7%
Cap/Sales 2.8%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 4.23
Quick Ratio 2.95
Altman-Z -7.46
F-Score3
WACC10.91%
ROIC/WACCN/A
Cap/Depr(3y)112.45%
Cap/Depr(5y)118.7%
Cap/Sales(3y)17.47%
Cap/Sales(5y)14.11%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)0.93%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-27.27%
EPS Next Y17.78%
EPS Next 2Y15.24%
EPS Next 3Y13.11%
EPS Next 5Y11.13%
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%37.28%
Revenue Next Year18.95%
Revenue Next 2Y18.69%
Revenue Next 3Y23.62%
Revenue Next 5Y22.46%
EBIT growth 1Y12.47%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year16.63%
EBIT Next 3Y14.24%
EBIT Next 5YN/A
FCF growth 1Y22.03%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y20.14%
OCF growth 3YN/A
OCF growth 5YN/A

RAPID MICRO BIOSYSTEMS INC-A / RPID Fundamental Analysis FAQ

Can you provide the ChartMill fundamental rating for RAPID MICRO BIOSYSTEMS INC-A?

ChartMill assigns a fundamental rating of 2 / 10 to RPID.


Can you provide the valuation status for RAPID MICRO BIOSYSTEMS INC-A?

ChartMill assigns a valuation rating of 0 / 10 to RAPID MICRO BIOSYSTEMS INC-A (RPID). This can be considered as Overvalued.


Can you provide the profitability details for RAPID MICRO BIOSYSTEMS INC-A?

RAPID MICRO BIOSYSTEMS INC-A (RPID) has a profitability rating of 0 / 10.


What is the expected EPS growth for RAPID MICRO BIOSYSTEMS INC-A (RPID) stock?

The Earnings per Share (EPS) of RAPID MICRO BIOSYSTEMS INC-A (RPID) is expected to grow by 17.78% in the next year.